BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32133372)

  • 1. Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis.
    Darlington A; McCauley MD
    Front Cardiovasc Med; 2020; 7():11. PubMed ID: 32133372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke.
    Qureshi A; Lip GYH; Nordsletten DA; Williams SE; Aslanidi O; de Vecchi A
    Front Cardiovasc Med; 2022; 9():1074562. PubMed ID: 36733827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
    Watson T; Shantsila E; Lip GY
    Lancet; 2009 Jan; 373(9658):155-66. PubMed ID: 19135613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is Atrial Fibrillation a Pre-Thrombotic State?].
    Uetsuka Y
    Rinsho Byori; 2015 Dec; 63(12):1427-34. PubMed ID: 27089660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prothrombotic state in atrial fibrillation: pathophysiological and management implications.
    Khan AA; Lip GYH
    Cardiovasc Res; 2019 Jan; 115(1):31-45. PubMed ID: 30388199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms.
    Cove CL; Albert CM; Andreotti F; Badimon L; Van Gelder IC; Hylek EM
    Thromb Haemost; 2014 Mar; 111(3):385-91. PubMed ID: 24305974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of thromboembolism in association with atrial fibrillation.
    Yamashita T
    Circ J; 2007; 71 Suppl A():A40-4. PubMed ID: 17587738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endothelium and atrial fibrillation. The prothrombotic state revisited.
    Freestone B; Lip GY
    Hamostaseologie; 2008 Oct; 28(4):207-12. PubMed ID: 18836646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.
    Ding WY; Gupta D; Lip GYH
    Heart; 2020 Oct; 106(19):1463-1468. PubMed ID: 32675218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism and risk factors of cardiogenic thromboembolism in patients with atrial fibrillation].
    Otsuka T
    Nihon Rinsho; 2013 Jan; 71(1):36-40. PubMed ID: 23631169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target.
    Regazzoli D; Ancona F; Trevisi N; Guarracini F; Radinovic A; Oppizzi M; Agricola E; Marzi A; Sora NC; Della Bella P; Mazzone P
    Biomed Res Int; 2015; 2015():205013. PubMed ID: 26236716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
    Goldman ME; Pearce LA; Hart RG; Zabalgoitia M; Asinger RW; Safford R; Halperin JL
    J Am Soc Echocardiogr; 1999 Dec; 12(12):1080-7. PubMed ID: 10588784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between lipoproteins, thrombosis, and atrial fibrillation.
    Ding WY; Protty MB; Davies IG; Lip GYH
    Cardiovasc Res; 2022 Feb; 118(3):716-731. PubMed ID: 33483737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
    Lip GY; Gibbs CR
    J Am Coll Cardiol; 1999 Apr; 33(5):1424-6. PubMed ID: 10193748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.
    Zabalgoitia M; Halperin JL; Pearce LA; Blackshear JL; Asinger RW; Hart RG
    J Am Coll Cardiol; 1998 Jun; 31(7):1622-6. PubMed ID: 9626843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
    Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation: villain or bystander in vascular brain injury.
    Freedman B; Kamel H; Van Gelder IC; Schnabel RB
    Eur Heart J Suppl; 2020 Nov; 22(Suppl M):M51-M59. PubMed ID: 33664640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombophilia in ischemic stroke subtypes: implications for treatment.
    Helgason CM
    Curr Treat Options Cardiovasc Med; 2006 May; 8(3):259-66. PubMed ID: 16635446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of Atrial Fibrillation in Combination with Left Atrial Appendage Occlusion in A Single Procedure. Rationale and Technique.
    Bolao IG; Calvo N; Macias A; Barba J; Salterain N; Ramos P; Ballesteros G; Neglia R
    J Atr Fibrillation; 2016; 8(5):1346. PubMed ID: 27909475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.